
Jon E. Angell
Examiner (ID: 3741, Phone: (571)272-0756 , Office: P/1674 )
| Most Active Art Unit | 1635 |
| Art Unit(s) | 1635, 1637, 1674 |
| Total Applications | 1431 |
| Issued Applications | 721 |
| Pending Applications | 199 |
| Abandoned Applications | 530 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5360537
[patent_doc_number] => 20090035331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-05
[patent_title] => 'Systems and Methods for Targeted and Controlled Delivery of Agents'
[patent_app_type] => utility
[patent_app_number] => 11/996793
[patent_app_country] => US
[patent_app_date] => 2007-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10338
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20090035331.pdf
[firstpage_image] =>[orig_patent_app_number] => 11996793
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/996793 | Systems and Methods for Targeted and Controlled Delivery of Agents | Jan 28, 2007 | Abandoned |
Array
(
[id] => 4899815
[patent_doc_number] => 20080119429
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-22
[patent_title] => 'METHODS AND MEANS FOR INCREASING RESISTANCE TO CELL DAMAGE'
[patent_app_type] => utility
[patent_app_number] => 11/615690
[patent_app_country] => US
[patent_app_date] => 2006-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 16489
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20080119429.pdf
[firstpage_image] =>[orig_patent_app_number] => 11615690
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/615690 | Methods and means for increasing resistance to cell damage | Dec 21, 2006 | Issued |
Array
(
[id] => 6418421
[patent_doc_number] => 20100167390
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-01
[patent_title] => 'Novel Oligonucleotide and NF-kB Decoy Comprising the Same'
[patent_app_type] => utility
[patent_app_number] => 12/086923
[patent_app_country] => US
[patent_app_date] => 2006-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6855
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20100167390.pdf
[firstpage_image] =>[orig_patent_app_number] => 12086923
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/086923 | Novel Oligonucleotide and NF-kB Decoy Comprising the Same | Dec 20, 2006 | Abandoned |
Array
(
[id] => 5126484
[patent_doc_number] => 20070238755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-11
[patent_title] => 'Methods to treat and/or prevent radiation- and/or chemical-induced toxicity in non-malignant tissue'
[patent_app_type] => utility
[patent_app_number] => 11/642505
[patent_app_country] => US
[patent_app_date] => 2006-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4968
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0238/20070238755.pdf
[firstpage_image] =>[orig_patent_app_number] => 11642505
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/642505 | Methods to treat and/or prevent radiation- and/or chemical-induced toxicity in non-malignant tissue | Dec 19, 2006 | Abandoned |
Array
(
[id] => 6351315
[patent_doc_number] => 20100249208
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-30
[patent_title] => 'Novel Methods and Models for Rapid, Widespread Delivery of Genetic Material to the CNS Using Non-Viral, Cationic Lipid-Mediated Vectors'
[patent_app_type] => utility
[patent_app_number] => 12/086605
[patent_app_country] => US
[patent_app_date] => 2006-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 28188
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20100249208.pdf
[firstpage_image] =>[orig_patent_app_number] => 12086605
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/086605 | Methods and models for rapid, widespread delivery of genetic material to the CNS using non-viral, cationic lipid-mediated vectors | Dec 13, 2006 | Issued |
Array
(
[id] => 6600310
[patent_doc_number] => 20100292297
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-18
[patent_title] => 'Micrornas That Regulate Muscle Cell Proliferation and Differentiation'
[patent_app_type] => utility
[patent_app_number] => 12/086109
[patent_app_country] => US
[patent_app_date] => 2006-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 32032
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20100292297.pdf
[firstpage_image] =>[orig_patent_app_number] => 12086109
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/086109 | Micrornas that regulate muscle cell proliferation and differentiation | Dec 11, 2006 | Issued |
Array
(
[id] => 5446155
[patent_doc_number] => 20090047381
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-19
[patent_title] => 'AMMONIA TRANSPORTER GENE AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/278995
[patent_app_country] => US
[patent_app_date] => 2006-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 9975
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0047/20090047381.pdf
[firstpage_image] =>[orig_patent_app_number] => 12278995
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/278995 | AMMONIA TRANSPORTER GENE AND USE THEREOF | Dec 4, 2006 | Abandoned |
Array
(
[id] => 5336895
[patent_doc_number] => 20090053359
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-26
[patent_title] => 'AMMONIA TRANSPORTER GENE AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/279080
[patent_app_country] => US
[patent_app_date] => 2006-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 9982
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20090053359.pdf
[firstpage_image] =>[orig_patent_app_number] => 12279080
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/279080 | AMMONIA TRANSPORTER GENE AND USE THEREOF | Dec 4, 2006 | Abandoned |
Array
(
[id] => 5178049
[patent_doc_number] => 20070179109
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-02
[patent_title] => 'DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION'
[patent_app_type] => utility
[patent_app_number] => 11/565839
[patent_app_country] => US
[patent_app_date] => 2006-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45695
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0179/20070179109.pdf
[firstpage_image] =>[orig_patent_app_number] => 11565839
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/565839 | DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION | Nov 30, 2006 | Abandoned |
Array
(
[id] => 5178046
[patent_doc_number] => 20070179106
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-02
[patent_title] => 'DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION'
[patent_app_type] => utility
[patent_app_number] => 11/565799
[patent_app_country] => US
[patent_app_date] => 2006-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45664
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0179/20070179106.pdf
[firstpage_image] =>[orig_patent_app_number] => 11565799
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/565799 | DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION | Nov 30, 2006 | Abandoned |
Array
(
[id] => 9965004
[patent_doc_number] => 09012620
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-21
[patent_title] => 'DNA constructs for specific inhibition of gene expression by RNA interference'
[patent_app_type] => utility
[patent_app_number] => 12/095062
[patent_app_country] => US
[patent_app_date] => 2006-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 6015
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 213
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12095062
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/095062 | DNA constructs for specific inhibition of gene expression by RNA interference | Nov 21, 2006 | Issued |
Array
(
[id] => 5056909
[patent_doc_number] => 20070059831
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-15
[patent_title] => 'Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis'
[patent_app_type] => utility
[patent_app_number] => 11/595990
[patent_app_country] => US
[patent_app_date] => 2006-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 19496
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20070059831.pdf
[firstpage_image] =>[orig_patent_app_number] => 11595990
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/595990 | Expression vector encoding apoptosis-specific eIF-5A | Nov 12, 2006 | Issued |
Array
(
[id] => 225066
[patent_doc_number] => 07605250
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-10-20
[patent_title] => 'siRNA targeting cAMP-specific phosphodiesterase 4D'
[patent_app_type] => utility
[patent_app_number] => 11/595112
[patent_app_country] => US
[patent_app_date] => 2006-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 33
[patent_no_of_words] => 35027
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/605/07605250.pdf
[firstpage_image] =>[orig_patent_app_number] => 11595112
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/595112 | siRNA targeting cAMP-specific phosphodiesterase 4D | Nov 8, 2006 | Issued |
Array
(
[id] => 5004514
[patent_doc_number] => 20070202082
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-30
[patent_title] => 'Promoters for RNA interference'
[patent_app_type] => utility
[patent_app_number] => 11/594623
[patent_app_country] => US
[patent_app_date] => 2006-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7237
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20070202082.pdf
[firstpage_image] =>[orig_patent_app_number] => 11594623
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/594623 | Promoters for RNA interference | Nov 6, 2006 | Abandoned |
Array
(
[id] => 6575701
[patent_doc_number] => 20100129429
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-27
[patent_title] => 'INHIBITION OF AUTOPHAGY GENES IN CANCER CHEMOTHERAPY'
[patent_app_type] => utility
[patent_app_number] => 12/092780
[patent_app_country] => US
[patent_app_date] => 2006-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 12606
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20100129429.pdf
[firstpage_image] =>[orig_patent_app_number] => 12092780
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/092780 | Inhibition of autophagy genes in cancer chemotherapy | Nov 2, 2006 | Issued |
Array
(
[id] => 1077028
[patent_doc_number] => 07615541
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-11-10
[patent_title] => 'siRNA targeting TIE-2'
[patent_app_type] => utility
[patent_app_number] => 11/593100
[patent_app_country] => US
[patent_app_date] => 2006-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 38
[patent_no_of_words] => 35636
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/615/07615541.pdf
[firstpage_image] =>[orig_patent_app_number] => 11593100
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/593100 | siRNA targeting TIE-2 | Nov 2, 2006 | Issued |
Array
(
[id] => 4840362
[patent_doc_number] => 20080280848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-13
[patent_title] => 'Structures of Active Guide Rna Molecules and Method of Selection'
[patent_app_type] => utility
[patent_app_number] => 12/091937
[patent_app_country] => US
[patent_app_date] => 2006-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 15482
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 30
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20080280848.pdf
[firstpage_image] =>[orig_patent_app_number] => 12091937
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/091937 | Structures of Active Guide Rna Molecules and Method of Selection | Oct 26, 2006 | Abandoned |
Array
(
[id] => 7527440
[patent_doc_number] => 08044032
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-10-25
[patent_title] => 'Selective killing of cells by activation of double-stranded RNA dependent protein kinase-PKR'
[patent_app_type] => utility
[patent_app_number] => 11/540505
[patent_app_country] => US
[patent_app_date] => 2006-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 21
[patent_no_of_words] => 10336
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/044/08044032.pdf
[firstpage_image] =>[orig_patent_app_number] => 11540505
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/540505 | Selective killing of cells by activation of double-stranded RNA dependent protein kinase-PKR | Oct 1, 2006 | Issued |
Array
(
[id] => 5422922
[patent_doc_number] => 20090149377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-11
[patent_title] => 'METHODS FOR REGULATION OF p53 TRANSLATION AND FUNCTION'
[patent_app_type] => utility
[patent_app_number] => 12/063463
[patent_app_country] => US
[patent_app_date] => 2006-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 30589
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0149/20090149377.pdf
[firstpage_image] =>[orig_patent_app_number] => 12063463
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/063463 | Methods for regulation of p53 translation and function | Sep 27, 2006 | Issued |
Array
(
[id] => 5434943
[patent_doc_number] => 20090169529
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-02
[patent_title] => 'COMPOSITIONS AND METHODS FOR IMMUNOSTIMULATORY RNA OLIGONUCLEOTIDES'
[patent_app_type] => utility
[patent_app_number] => 12/066903
[patent_app_country] => US
[patent_app_date] => 2006-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 73
[patent_figures_cnt] => 73
[patent_no_of_words] => 33335
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0169/20090169529.pdf
[firstpage_image] =>[orig_patent_app_number] => 12066903
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/066903 | Method for determining immunostimulatory activity of RNA oligonucleotides | Sep 13, 2006 | Issued |